Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling

Rongrong Zhao(Anhui Medical University), Roger Foo(Institute of Molecular and Cell Biology), Matthew Ackers‐Johnson(National University of Singapore), Yue Zhou(Shanghai Medical College of Fudan University), James W. Fawcett(Allen Institute for Brain Science), Peter Y. Li(National University of Singapore), Shi Ling Ng(Genome Institute of Singapore), Pauline M. Rudd(St Bartholomew's Hospital), Peipei Wang(Jinan University), Chen Chen(Tongji Hospital), Justus Stenzig(Universität Hamburg), Tao Ding(National University of Singapore), Gavin Teo(Bioprocessing Technology Institute)
Circulation
January 25, 2018
10.1161/circulationaha.117.030353
Cited by 62

Related Papers

Symbol Nomenclature for Graphical Representations of Glycans
|Glycobiology|2015|1.1k
Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials
|Spinal Cord|2006|872
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations
|Molecular & Cellular Proteomics|2011|533
Updates to the Symbol Nomenclature for Glycans guidelines
|Glycobiology|2019|486